Company: INMB
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003354
Chunk: 85

Company: Inmune Bio, Inc.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1
Chunk 85
---
, and security measures to protect
our confidential and proprietary information. These measures may not adequately protect our trade secrets or other proprietary information.
If they do not adequately protect our rights, third parties could use our technology, and we could lose any competitive advantage we may
have. In addition, others may independently develop similar proprietary information or techniques or otherwise gain access to our trade
secrets, which could impair any competitive advantage we may have.

Patent protection and other
intellectual property protection is crucial to the success of our business and prospects, and there is a substantial risk that such protections
will prove inadequate.

By working with research collaborators
patent rights may be jointly owned by different parties.

Certain
of our licensors may have relied on third-party consultants or collaborators such that our licensors are not the sole and exclusive owners
of the patents we in-licensed. If other third parties have ownership rights to our in-licensed patents, the license granted to us for
such jointly owned patents may not be valid. Absent an agreement, each joint owner can independently sell, license, or otherwise exploit
the jointly owned patent without the approval of the other joint owner(s) and without having to account to each other for their revenues.
Without the cooperation of all joint owners, none can grant an exclusive license to a third party. Further, a jointly owned patent cannot
be enforced unless all of the owners join in the lawsuit. If a co-owner refuses to participate, the lawsuit cannot proceed. Certain of
our in-licensed patents from Xencor show joint ownership between Xencor and a third party. Xencor provided representations and warrants
as to its ability to grant the rights provided in the license. In addition, Xencor is required to indemnify us as to any breach of its
representations, warranties and covenants made in the agreement.

Further,
our rights to current or future in-licensed patents and patent applications may be dependent, in part, on inter-institutional or other
operating agreements between the joint owners of such in-licensed patents and patent applications. If one or more of such joint owners
breaches such inter-institutional or operating agreements, our rights to such in-licensed patents and patent applications may be adversely
affected. Any of these events could have a material adverse effect on our competitive position, business, financial conditions, results
of operations, and prospects.

Intellectual property discovered through
government funded programs may be subject to federal regulations such as “march-in” rights